Eli Lilly and Company ( LLY) - Key Metrics

LLY Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $25.74 $7.95 $11.98 $8.69
2026Q1 $22.13 $8.27 $5.96 $3.36
2025Q4 $21.48 $7.39 $3.59 $0.75
2025Q3 $19.62 $6.22 $9.85 $9.60
2025Q2 $17.33 $6.30 $3.44 $1.43

LLY Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 21.79% 37.72
2026Q1 20.93% 27.80
2025Q4 20.28% 36.26
2025Q3 24.10% 30.67
2025Q2 23.80% 30.93

LLY Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.72% 0.14%
2026Q1 0.37% 0.19%
2025Q4 0.07% 0.14%
2025Q3 1.26% 0.20%
2025Q2 0.18% 0.19%

LLY

Price: $1,148.20

52 week price:
712.05
1292.65

Dividend Yield: 0.58%

5-year range yield:
0.58%
1.79%

Forward Dividend Yield: 0.60%

Payout Ratio: 63.73%

Payout Ratio Range:
-16062.50%
328.65%

Dividend Per Share: 6.92 USD

Earnings Per Share: 29.81 USD

P/E Ratio: 40.76

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 2.6 million

Ebitda: 758.9 million

Market Capitalization: 1.1 trillion

Average Dividend Frequency: 4

Years Paying Dividends: 55

DGR3: 16.81%

DGR5: 16.09%

DGR10: 11.89%

DGR20: 7.42%

Links: